Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis

References

• Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521–7
   PubMedGoogle Scholar
• Toner JP, Philput CB, Jones GS, Muasher SJ. Basal folliclestimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784–91
   PubMed Web of Science ®Google Scholar
• Wardle PG, Mitchell JD, McLaughlin EA, et al. Endometriosis and ovulatory disorder: reduced fertilization in vitro compared with tubal and unexplained infertility. Lancet 1985;2:236–9
   PubMedGoogle Scholar
• Keay SD, Liversedge NH, Jenkins JM. Could ovarian infection impair ovarian response to gonadotrophin stimulation? Br J Obstet Gynaecol 1998;105:252–3
   PubMedGoogle Scholar
• Ben-Rafael Z, Strauss JF 3rd, Mastroianni L Jr, Flickinger GL. Differences in ovarian stimulation in human menopausal gonadotrophin treated woman may be related to follicle-stimulating hormone accumulation. Fertil Steril 1986;46:586–92
   PubMedGoogle Scholar
• Pandian Z, McTavish AR, Aucott L, et al. Interventions for ‘poor responders’ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev 2010;20:CD004379
   Google Scholar
• Howles CM, Loumaye E, Germond M, et al. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? Hum Reprod 1999;14:1939–43
   PubMed Web of Science ®Google Scholar
• Lok IH, Yip SK, Cheung LP, et al. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril 2004;81:556–61
   PubMed Web of Science ®Google Scholar
• Sunkara SK, Pundir J, Khalaf Y. Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis. Reprod Biomed Online 2011;22:545–55
   PubMed Web of Science ®Google Scholar
• Placido GD, Alviggi C, Mollo A, et al. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrinol (Oxf) 2004;60:637–43
   PubMedGoogle Scholar
• Fleming R, Lloyd F, Herbert M, et al. Effect of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function inj cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998;13:1788–92
   PubMed Web of Science ®Google Scholar
• Westergaard JG, Erb K, Laursen SB, et al. Human menopausal gonadotropin versus recombinant follicle stimulating hormone in normogonadotropic women down-regulated with a gonadotropinreleasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmatic spoerm injection: a prospective randomised study. Fertil Steril 2001;76:543–9
   PubMed Web of Science ®Google Scholar
• Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000;15:1003–8
   PubMed Web of Science ®Google Scholar
• Mochtar MH, Van der Veen Ziech M, van Wely M. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007;18:CD005070
   Google Scholar
• Loutradis D, Vomvolaki E, Drakakis P, et al. Poor responder protocols for in-vitro fertilization: options and results. Curr Opin Obstetr Gynecol 2008;20:374–8
   PubMed Web of Science ®Google Scholar
• Kavvoura FK, Ioannidis JP. CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 2005;162:3–16
   PubMed Web of Science ®Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820–6
   PubMed Web of Science ®Google Scholar
• Ferraretti AP, Gianaroli L, Magli MC, et al. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004;82:1521–6
   PubMed Web of Science ®Google Scholar
• De Placido G, Alviggi C, Perino A, et al. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005;20:390–6
   PubMed Web of Science ®Google Scholar
• Barrenetxea G, Agirregoikoa JA, Jiménez MR, et al. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008;89:546–53
   PubMedGoogle Scholar
• Musters AM, van Wely M, Mastenbroek S, et al. The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve. Hum Reprod 2012;27:244–50
   PubMed Web of Science ®Google Scholar
• Chung K, Krey L, Katz J, Noyes N. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists. Fertil Steril 2005;84:313–8
   PubMed Web of Science ®Google Scholar
• Tarlatzis B, Tavmergen E, Szamatowicz M, et al. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study. Hum Reprod 2006;21:90–4
   PubMed Web of Science ®Google Scholar
• Penarrubia J, Fabregues F, Creus M, et al. LH serum levels during ovarian stimultion as predictors of ovarian response and assisted reproduction outcome in down-regulated women estimulated with recombinant FSH. Hum Reprod 2003;18:2689–97
   PubMed Web of Science ®Google Scholar
• Kolibianakis EM, Kalogeropoulou L, Griesinger G, et al. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update 2007;13:445–52
   PubMed Web of Science ®Google Scholar
• Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Fertil Steril 2007;88:665–9
   PubMed Web of Science ®Google Scholar
• Fabregues F, Creus M, Penarrubia J, et al. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertil Steril 2006; 85:925–31
   PubMed Web of Science ®Google Scholar
• Hughes EG. Systematic literature review and meta-analysis. Semin Reprod Endocrinol 1996;14:161–9
   PubMedGoogle Scholar
• Guyatt GH, Sackett DL, Cook DJ. Users’ guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-based medicine working group. JAMA 1993;270:2598–601
   PubMed Web of Science ®Google Scholar
• Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408–12
   PubMed Web of Science ®Google Scholar
• Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609–13
   PubMed Web of Science ®Google Scholar
• Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42–6
   PubMed Web of Science ®Google Scholar
• Cohlen BJ, Vandekerckhove P, te Velde ER, Habbema JD. Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men. Cochrane Database Syst Rev 2000;(2):CD000360
   PubMedGoogle Scholar
• Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of ‘poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–24
   PubMed Web of Science ®Google Scholar